Concepedia

Emmanuel Chigutsa

EC

Statistics

Publications

22

Citations

1.3K

H-Index

18

Active since

2007

Affiliations

Eli Lilly (United States)(Current)

University of Cape Town

University of the Western Cape

Odense University Hospital

Velocity Clinical Research (United States)

Emmanuel Chigutsa is an author at Eli Lilly (United States) specializing in pharmacology, pharmacokinetics, and pharmacy.

Publications per year

2007–2023

22

Publications

22

High prevalence of the CYP2B6 516G→T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe

Christopher Nyakutira, Daniel Röshammar, Emmanuel Chigutsa et al. · European Journal of Clinical Pharmacology · 2007 · 214 citations

, , +17

The <i>SLCO1B1</i> rs4149032 Polymorphism Is Highly Prevalent in South Africans and Is Associated with Reduced Rifampin Concentrations: Dosing Implications

Emmanuel Chigutsa, Marianne E Visser, Paolo Denti et al. · Antimicrobial Agents and Chemotherapy · 2011 · 147 citations · Full text

, , +16

Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis

Emmanuel Chigutsa, Jotam G. Pasipanodya, Marianne E. Visser et al. · Antimicrobial Agents and Chemotherapy · 2014 · 134 citations · Full text

, , +13

Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania

Paolo Denti, Kidola Jeremiah, Emmanuel Chigutsa et al. · PLoS ONE · 2015 · 100 citations · Full text

, , +15

Bebtelovimab, alone or together with bamlanivimab and etesevimab, as a broadly neutralizing monoclonal antibody treatment for mild to moderate, ambulatory COVID-19

Michael Dougan, Masoud Azizad, Peter Chen et al. · medRxiv · 2022 · 75 citations · Full text

, , +14

1–5 of 22